Phibro Animal Health Corporation (PAHC) Financials

PAHC Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.4 billion 1.1 billion
Dec. 31, 2025 1.4 billion 1.1 billion
Sept. 30, 2025 1.4 billion 1.1 billion
June 30, 2025 1.4 billion 1.1 billion

PAHC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 890000 ?
Dec. 31, 2025 8.3 million 434000
Sept. 30, 2025 -4.5 million 339000
June 30, 2025 8.1 million 179000

PAHC Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 24.0 million
Dec. 31, 2025 27.5 million
Sept. 30, 2025 26.5 million
June 30, 2025 17.2 million

PAHC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 77.5 million 712.7 million 42.5 million
Dec. 31, 2025 74.5 million 710.6 million 41.9 million
Sept. 30, 2025 85.3 million 724.5 million 42.1 million
June 30, 2025 77.0 million 702.4 million 42.9 million

PAHC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 41.0 million
Dec. 31, 2025 41.0 million
Sept. 30, 2025 40.9 million
June 30, 2025 40.7 million

PAHC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 15.3 million - 76.9 million -
Dec. 31, 2025 11.1 million - 77.9 million -
Sept. 30, 2025 13.8 million - 71.5 million -
June 30, 2025 13.1 million 23.7 million 76.3 million -

PAHC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 383.5 million 257.9 million
Dec. 31, 2025 373.9 million 241.3 million
Sept. 30, 2025 363.9 million 244.1 million
June 30, 2025 378.7 million 268.7 million

PAHC Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PAHC

Price: $32.07

52 week price:
25.58
60.08

Dividend Yield: 1.45%

5-year range yield:
0.82%
4.92%

Forward Dividend Yield: 1.50%

Payout Ratio: 800.00%

Payout Ratio Range:
-60.64%
800.00%

Dividend Per Share: 0.48 USD

Earnings Per Share: 2.33 USD

P/E Ratio: 15.59

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 51500

Ebitda: 30.9 million

Market Capitalization: 1.3 billion

Average Dividend Frequency: 4

Years Paying Dividends: 13

DGR10: 1.93%

Links: